Patenting and licensing in genetic testing

Patenting and Licensing and Biomedical Innovation

Over the last two decades changes in technology and policy have altered the landscape of drug discovery. These changes have led to concerns that the patent system may be creating difficulties for those trying to do research in biomedical fields. Using interviews and archival data, we examine the changes in patenting in recent years and how these have affected innovation in pharmaceuticals and r...

The Growth of Patenting and Licensing

invaluable assistance with the collection and analysis of these data. The research on the Columbia University data underpinning this paper also benefited from the efforts of Michael Crow, Introduction The U.S. research university and the organized pursuit of R&D in industry both originated roughly 125 years ago and have grown in parallel throughout the 20th century (Mowery and Rosenberg, 1998)....

Optimal Patenting and Licensing of Financial Innovations1

Recent court decisions, starting with the State Street decision in 1998, allow business methods to be patentable and now give …nancial institutions the option to seek patent protection for …nancial innovations. This new patentability paradigm and the heterogeneity of characteristics associated with …nancial innovations, poses an immediate decision problem for senior management: what to patent. ...

Research Tool Patenting and Licensing and Biomedical Innovation

Patenting of Genetic Inventions

The genetic inventions in the patent system are similar to chemical inventions. Genetic inventions that are patentable include genetic materials such as DNA, RNA, cDNA, EST’s (Expressed Sequence Tags), SNPs (Single Nucleotide Polymorphs) and recombinant vectors. These inventions need to satisfy the criteria of patentability such as novelty, nonobviousness, utility, enablement and sufficiency of...